[ Price : $8.95]
Federal Register notice: FDA permanently debars Raidel Figueroa from providing services in any capacity to a person that has an ap...[ Price : $8.95]
Regeneron says it has discontinued enrollment in a Phase 1 prostate cancer study of REGN5678, which is studying the combination us...[ Price : $8.95]
FDA discusses a new drug safety initiative that aims to develop artificial intelligence models for toxicological endpoints that ar...[ Price : $8.95]
FDA releases a final guidance entitled Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDS...[ Price : $8.95]
FDA sends Mesoblast a second complete response letter on its BLA for remestemcel-L for treating pediatric steroid-refractory acute...[ Price : $8.95]
FDA approves new labeling to permit several Biosense Webster cardiac ablation devices to be used without relying on a fluoroscopy ...[ Price : $8.95]
Federal Register notice: FDA announces a 10/18-19 public meeting entitled Mitigating Clinical Study Disruptions During Disasters a...[ Price : $8.95]
Federal Register notice: FDA posts a draft guidance entitled PDUFA Waivers, Reductions, and Refunds for Fixed-Combinations and Sin...